Due to genetic variation, patients metabolize and respond to medications in vastly different ways, so why do most drug therapy regimens continue to be one-size-fits-all? In this interview, Dr. Yuan Ji, ARUP’s section chief of Molecular Genetics and Genomics, discusses how currently available genetic tests can be used to improve both the safety and effectiveness of pharmacotherapy.

Related Content:
Current Clinical Pharmacogenomic Testing: How Do Clinical Laboratories Stay on Top of Changes to Technologies, Professional Guidelines, and Regulations?   https://arup.utah.edu/education/ji-pharmtest-2024.php